THE WHAT? L’Oréal has announced a strategic partnership with French biotech Microphyt, which sees L’Oréal’s venture capital fund, BOLD (Business Opportunities for L’Oréal Development) acquire a minority stake in the firm.
THE DETAILS L’Oréal and Microphyt will build a technological platform and will bring material and human resources together to create raw materials from microalgae biomass.
“The ambition of both companies is to establish a long-term partnership for the development of new cosmetic solutions,” according to a press release.
The tie up comes after several strategic scientific partnerships recently forged by L’Oréal to strengthen its pioneering Green Sciences ecosystem of Beauty. These include the precision-health company VERILY, the National Institute for Materials Sciences (NIMS) in Japan, the Singapore Centre for Environmental Life Sciences Engineering (SCELSE) or the Laboratoire de Chimie des Polymères Organiques (LCPO) in Bordeaux.
THE WHY? According to a press release, “This partnership is an additional proof point of L’Oréal’s Research and Innovation strategy towards Greens Science and its investment in innovative biotech start-ups in France, and across the world.
“This proactive strategy is at the heart of L’Oréal’s 2030 sustainable development program, including the objective that 95% of its ingredients will be bio-sourced, derived from abundant minerals or from circular processes.”
Barbara Lavernos, Deputy CEO, in charge of Research, Innovation and Technology, L’Oréal Group, said: “Our ambition is to collaborate across the world with the most disruptive scientific entities in Green Sciences, in order to collectively develop responsible innovations on a large scale and make them available to as many people as possible.
“We are very pleased to pursue this new partnership with Microphyt, which will enable us, thanks to its unique natural solutions derived from microalgae, to further accelerate our drive towards more sustainable beauty.”
Medical aesthetic products refer to a category of products used in the field of medical aesthetics, which combines medical practices with cosmetic procedures to improve the appearance of individuals. These products are typically used under the supervision of trained medical professionals such as dermatologists, plastic surgeons, or specialized nurses. They are distinct from over-the-counter cosmetics in that they often contain higher concentrations of active ingredients or require medical expertise for their application.
Examples of medical aesthetic products include:
-
Dermal Fillers: Injectable substances used to restore volume, fill wrinkles, and enhance facial contours. These may include hyaluronic acid fillers like Juvederm or collagen-stimulating fillers like Sculptra.
-
Botulinum Toxin (Botox): Injectable neurotoxins used to temporarily paralyze facial muscles, reducing the appearance of wrinkles and fine lines caused by facial expressions.
-
Chemical Peels: Solutions containing chemical exfoliants like glycolic acid, salicylic acid, or trichloroacetic acid, used to improve skin texture, treat acne scars, and reduce hyperpigmentation.
-
Laser and Light Devices: Equipment used for various skin treatments, including hair removal, skin resurfacing, tattoo removal, and treatment of vascular and pigmented lesions.
-
Prescription Skincare Products: Formulations containing active ingredients such as retinoids (e.g., tretinoin), hydroquinone, or prescription-strength antioxidants, designed to address specific dermatological concerns under medical supervision.
-
Microneedling Devices: Devices that create tiny punctures in the skin to stimulate collagen production and improve skin texture and elasticity.
-
Cosmeceuticals: High-quality skincare products that bridge the gap between cosmetics and pharmaceuticals, often containing biologically active ingredients with proven efficacy.
Leave a Reply
You must be logged in to post a comment.